Readystate Asset Management LP Pfizer Inc Call Options Transaction History

Readystate Asset Management LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $11 Million - $12.5 Million	398,800 Added 1954.9%	419,200 $12.1 Billion
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $111 Million - $130 Million	-4,400,000 Reduced 99.54%	20,400 $571 Million
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $13.1 Million - $15 Million	504,100 Added 12.87%	4,420,400 $123 Billion
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $102 Million - $133 Million	3,916,300 New	3,916,300 $113 Billion
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $299,364 - $389,728	7,600 New	7,600 $310 Million

3,258

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Readystate Asset Management LP with notifications on news.